NCT03995381 (N201902036) is a NA clinical trial of Decision aids in Haemostatic Adverse Reaction, sponsored by Taipei Medical University Shuang Ho Hospital.

Who is sponsoring NCT03995381?

NCT03995381 is sponsored by Taipei Medical University Shuang Ho Hospital.

What drugs are being tested in NCT03995381?

Interventions in NCT03995381: Decision aids.

What condition does NCT03995381 study?

NCT03995381 studies Haemostatic Adverse Reaction.

Is NCT03995381 still recruiting?

NCT03995381 is currently status unknown. Last updated 19 September 2019.

Last reviewed 2019-09-19 · How we verify

NCT03995381: N201902036

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Using Decision Aids to Reducing Decision Conflict in Angiography Patients for Choosing Hemostasis

Status unknown NA Last updated 19 September 2019

What this trial tests

NA trial testing Decision aids in Haemostatic Adverse Reaction in 150 participants. Status unknown.

Timeline

1 October 2019

Primary endpoint
31 December 2020

31 December 2021

Quick facts

Lead sponsor	Taipei Medical University Shuang Ho Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	150
Start date	1 October 2019
Primary completion	31 December 2020
Estimated completion	31 December 2021
Sites	1 location across Taiwan

Drugs / interventions tested

Decision aids

Conditions studied

Haemostatic Adverse Reaction — all drugs for Haemostatic Adverse Reaction →

Sponsor

Taipei Medical University Shuang Ho Hospital

Who can join

Adults 18 to 75, any sex, with Haemostatic Adverse Reaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Vascular closure device, hemostatic bandage and manual compression can achieve hemostasis after angiographic examination. These three methods of hemostasis changed the rate of hemostasis, early ambulation, hematoma , hemostasis failure rate, and expense. Therefore, shared decision making (SDM) is necessary to aid patients to choose hemostasis.The investigators have developed a decision aids (DA) and planned a randomized controlled trial (RCT) to evaluate its impact on angiographic patients. The measurements include a battery of interview-based questionnaires and evaluations of decision conflicts. The investigators expect the DAs would benefit the intervention group in the aspects of knowledge, communication and choice conflicts.during and after thier Hemostasis procedure.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Decision aids for people facing health treatment or screening decisions.
Stacey D, Lewis KB, Smith M, Carley M, et al · · 2024 · cited 203× · PMID 38284415 · DOI 10.1002/14651858.cd001431.pub6

Verify or expand the search:

Other trials of Decision aids

Trials testing the same drug.

NCT04101409 — Impact of Shared Decision-Making With Decision Aids on Acoustic Neuroma Treatment Choice: A Randomized Controlled Trial · NA · unknown
NCT03804489 — Using "Decision Aids" to Help the Infant Family to Decide the Use of Oral Rotavirus Vaccine · NA · unknown
NCT03105076 — Impact of Decision Aids on Breast Cancer Surgery Choice: A Randomized Controlled Trial · NA · completed

Other Taipei Medical University Shuang Ho Hospital trials

Trials by the same sponsor.

NCT07380685 — On-Demand AI Support Via LINE-Based GPT Assistant to Improve Emotional Resilience and Reduce Burnout Among Clinical Nurs · NA · not yet recruiting
NCT07435714 — Facilitating Surgical Choice in Patient With Chronic Hypertrophic Rhinitis Using a Patient Decision Aid · NA · not yet recruiting
NCT07230366 — Clinical Validation of AI-powered Smart Vehicle Assisted Gait Training in Neurodegenerative Disorders · NA · not yet recruiting
NCT07257393 — Fall Risk Assessment in Parkinson's Disease Using Kinetikos Health · not yet recruiting
NCT07192042 — Investigation of Using Non-Wearable Devices to Assess Sleep- Disordered Breathing in Hospitalized Patients With Schizoph · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03995381 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University Shuang Ho Hospital
Last refreshed: 19 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03995381.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing